Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01111825
Title Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Puma Biotechnology, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | GBR | FRA | ESP | DNK

Facility Status City State Zip Country Details
Western Regional Medical Center, Inc. Goodyear Arizona 85338 United States Details
USC/Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Memorial Sloan Kettering Cancer Center (MSKCC) New York New York 10065 United States Details
Weill Cornell Medical College - New York - Presbyterian Hospital New York New York 10065 United States Details
Roskilde Hospital Roskilde 4000 Denmark Details
Institut Gustave Roussy Villejuif 94800 France Details
UNIMED Medical Institute Wan Chai Hong Kong Details
Hospital Universitario Sant Joan de Reus Tarragona Reus 43204 Spain Details
Hospital Universitario Vall d'Hebron Barcelona 08035 Spain Details
Hospital Universitari Arnau de Vilanova de Lleida Lleida 25006 Spain Details
Edinburgh Cancer Center, Western General Hospital Edinburgh EH4 2XU United Kingdom Details
The Royal Marsden NHS Foundation Trust London SW3 6JJ United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field